Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleFocus on Molecular Imaging

Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy

Yubin Miao and Thomas P. Quinn
Journal of Nuclear Medicine March 2021, 62 (3) 313-318; DOI: https://doi.org/10.2967/jnumed.120.243840
Yubin Miao
1Department of Radiology, School of Medicine, University of Colorado Denver, Aurora, Colorado; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas P. Quinn
2Department of Biochemistry, University of Missouri–Columbia, and Harry S. Truman Veterans’ Hospital, Columbia, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. 3 313-318
DOI 
https://doi.org/10.2967/jnumed.120.243840
PubMed 
33277401

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 29, 2020
  • Accepted for publication November 20, 2020
  • Published online February 23, 2021.

Article Versions

  • previous version (December 4, 2020 - 12:52).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Yubin Miao1 and
  2. Thomas P. Quinn2
  1. 1Department of Radiology, School of Medicine, University of Colorado Denver, Aurora, Colorado; and
  2. 2Department of Biochemistry, University of Missouri–Columbia, and Harry S. Truman Veterans’ Hospital, Columbia, Missouri
  1. For correspondence or reprints contact: Yubin Miao, Department of Radiology, School of Medicine, University of Colorado Denver, 12700 E. 19th Ave., Aurora, CO 80045. E-mail: yubin.miao{at}cuanschutz.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 19 Citations
  • 22 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
    Juan Sun, Zhenyuan Huangfu, Jiangtao Yang, Guanglin Wang, Kuan Hu, Mingyuan Gao, Zhiyuan Zhong
    Advanced Drug Delivery Reviews 2022 190
  • Skin Cancer Pathobiology at a Glance: A Focus on Imaging Techniques and Their Potential for Improved Diagnosis and Surveillance in Clinical Cohorts
    Elena-Georgiana Dobre, Mihaela Surcel, Carolina Constantin, Mihaela Adriana Ilie, Ana Caruntu, Constantin Caruntu, Monica Neagu
    International Journal of Molecular Sciences 2023 24 2
  • MC1R and melanin-based molecular probes for theranostic of melanoma and beyond
    Hui Shi, Zhen Cheng
    Acta Pharmacologica Sinica 2022 43 12
  • Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
    Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, Timo W. M. De Groof, Dora Mugoli Chigoho, Parinaz Asiabi, Peter Covens, Matthias D’Huyvetter, Nick Devoogdt
    Pharmaceutics 2023 15 5
  • Peptides for diagnosis and treatment of ovarian cancer
    Ling Guo, Jing Wang, Nana Li, Jialin Cui, Yajuan Su
    Frontiers in Oncology 2023 13
  • Combined Probe Strategy to Increase the Enzymatic Digestion Rate and Accelerate the Renal Radioactivity Clearance of Peptide Radiotracers
    Mingru Zhang, Jiajun Ye, Zhaojuan Xie, Yirong Wang, Wenhui Ma, Fei Kang, Weidong Yang, Jing Wang, Xiaoyuan Chen
    Molecular Pharmaceutics 2022 19 5
  • Toward Clinical Transfer of Tumor‐Targeted Ultrasmall Inorganic Nanoparticles
    Léna Carmès, Mainak Banerjee, Pierre Coliat, Sébastien Harlepp, Xavier Pivot, Olivier Tillement, François Lux, Alexandre Detappe
    Advanced Therapeutics 2023 6 9
  • Synthesis and Preclinical Evaluation of a 68Ga-Labeled Pyridine-Based Benzamide Dimer for Malignant Melanoma Imaging
    Tingting Wang, Pengfei Xu, Jianyang Fang, Cijuan Li, Xinying Zeng, Jia Liu, Lingxin Meng, Rongqiang Zhuang, Xianzhong Zhang, Xinhui Su, Zhide Guo
    Molecular Pharmaceutics 2023 20 2
  • Elevating theranostics: The emergence and promise of radiopharmaceutical cell‐targeting heterodimers in human cancers
    Claudia Chambers, Broc Chitwood, Charles J. Smith, Yubin Miao
    iRADIOLOGY 2024 2 2
  • Brain metastasis: An insight into novel molecular targets for theranostic approaches
    Liliana Santos, João Nuno Moreira, Antero Abrunhosa, Célia Gomes
    Critical Reviews in Oncology/Hematology 2024 198

Article usage

Article usage: December 2020 to April 2025

AbstractFullPdf
Dec 2020571038
Jan 2021321012
Feb 20216695570
Mar 202112169756
Apr 20213822927
May 2021223810
Jun 202117146
Jul 202114655
Aug 20211512938
Sep 2021384033
Oct 2021526556
Nov 2021434432
Dec 2021266531
Jan 2022274440
Feb 2022426226
Mar 2022237561
Apr 202284540
May 2022304452
Jun 2022174345
Jul 2022204437
Aug 202272513
Sep 202283333
Oct 202242925
Nov 202292116
Dec 2022133819
Jan 202373222
Feb 2023174426
Mar 2023163233
Apr 202342817
May 202382721
Jun 2023133425
Jul 2023112333
Aug 2023193224
Sep 2023181829
Oct 202383821
Nov 2023132625
Dec 2023104112
Jan 2024157321
Feb 2024173934
Mar 2024144059
Apr 2024174525
May 2024278026
Jun 2024133438
Jul 2024182334
Aug 2024235131
Sep 2024133228
Oct 2024124436
Nov 2024125137
Dec 2024114029
Jan 2025123319
Feb 2025148420
Mar 2025165547
Apr 202596739
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (3)
Journal of Nuclear Medicine
Vol. 62, Issue 3
March 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
Yubin Miao, Thomas P. Quinn
Journal of Nuclear Medicine Mar 2021, 62 (3) 313-318; DOI: 10.2967/jnumed.120.243840

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
Yubin Miao, Thomas P. Quinn
Journal of Nuclear Medicine Mar 2021, 62 (3) 313-318; DOI: 10.2967/jnumed.120.243840
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MC1R-TARGETED DIAGNOSTIC AND THERAPEUTIC α-MELANOCYTE–STIMULATING HORMONE (α-MSH) PEPTIDES
    • MC1R-TARGETED α-MSH-FUNCTIONALIZED DIAGNOSTIC AND THERAPEUTIC C′ DOTS
    • VLA-4–TARGETED DIAGNOSTIC AND THERAPEUTIC LLP2A PEPTIDES
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Pre-clinical Evaluation of Biomarkers for Early Detection of Nephrotoxicity Following Alpha-particle Radioligand Therapy
  • Google Scholar

More in this TOC Section

  • From Genome to Phenome: Opportunities and Challenges of Molecular Imaging
  • Imaging the Activity of Efflux Transporters at the Blood–Brain Barrier in Neurologic Diseases: Radiotracer Selection Criteria
  • Molecular Imaging of Pulmonary Fibrosis
Show more Focus on Molecular Imaging

Similar Articles

Keywords

  • melanocortin-1 receptor
  • very late antigen-4
  • peptide radiopharmaceuticals
  • Cornell prime dots
  • melanoma imaging and therapy
SNMMI

© 2025 SNMMI

Powered by HighWire